Cargando…
Single Chain Antibodies Against gp55 of Human Cytomegalovirus (HCMV) for Prophylaxis and Treatment of HCMV Infections
BACKGROUND: Immunotherapy is a promising prospective new treatment for cytomegalovirus (CMV) infections. Neutralizing effects have been reported using monoclonal antibodies. Recombinant single chain antibodies (scFvs) due to their advantages over monoclonal antibodies are potential alternatives and...
Autores principales: | Moazen, Bahareh, Ebrahimi, Elahe, Nejatollahi, Foroogh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Kowsar
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4870390/ https://www.ncbi.nlm.nih.gov/pubmed/27217918 http://dx.doi.org/10.5812/jjm.16241 |
Ejemplares similares
-
Association of human cytomegalovirus (HCMV) neutralizing antibodies with antibodies to the HCMV glycoprotein complexes
por: Shibamura, Miho, et al.
Publicado: (2020) -
Suppressive effects of pterostilbene on human cytomegalovirus (HCMV) infection and HCMV-induced cellular senescence
por: Wang, Sanying, et al.
Publicado: (2022) -
Human Cytomegalovirus (HCMV)-infected Astrocytoma Cells Impair the Function of HCMV-specific Cytotoxic T Cells
por: Kim, Jiyeon, et al.
Publicado: (2020) -
Gene cloning of the human cytomegalovirus (HCMV) antigen reactive with the serum from a HCMV-infected patient.
por: Kim, M. N., et al.
Publicado: (1994) -
The microRNA Transcriptome of Human Cytomegalovirus (HCMV)
por: Meshesha, Mesfin K, et al.
Publicado: (2012)